Hematopoietic Progenitor Kinase1 (HPK1) Mediates T Cell Dysfunction and Is a Druggable Target for T Cell-Based Immunotherapies
造血祖细胞激酶 1 (HPK1) 介导 T 细胞功能障碍,是 T 细胞免疫疗法的可用药靶点
期刊:Cancer Cell
影响因子:48.8
doi:10.1016/j.ccell.2020.08.001
Jingwen Si, Xiangjun Shi, Shuhao Sun, Bin Zou, Yaopeng Li, Dongjie An, Xingyu Lin, Yan Gao, Fei Long, Bo Pang, Xing Liu, Tian Liu, Wenna Chi, Ligong Chen, Dimiter S Dimitrov, Yan Sun, Xinru Du, Wen Yin, Guangxun Gao, Junxia Min, Lai Wei, Xuebin Liao